MedPath

A Retrospective Study on the Effect of HBA or HBB Genetic Defects on Early Embryonic Development

Completed
Conditions
Thalassemia,Embryonic Development,Reproductive Sterility and Infertility
Interventions
Procedure: Preimplantation genetic diagnosis
Registration Number
NCT03687567
Lead Sponsor
Reproductive & Genetic Hospital of CITIC-Xiangya
Brief Summary

Thalassemia is an anemia or pathological state caused by compounding absently or inadequately of one or more globin chains of hemoglobin due to the defects of the globin gene,and the carrying rate is high in southern China. Although there are many studies of Thalassemia, the relationship between the globin gene defects and the early embryo development has not been reported.

This study intends to carry out a retrospective analysis on the embryonic development of the patients with thalassemia assisted by PGD from January 1, 2011 to now in our hospital, to explore whether the HBA or HBB gene defects have a certain influence on the early embryo development, so as to accumulate certain data for reproductive health research.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
737
Inclusion Criteria
  • infertility couples with thalassemia(one or both )
  • infertility couples treat by PGD
Exclusion Criteria
  • abortion of amplification for blastula biopsy
  • PGD without diagnostic results or with unclear diagnostic results
  • embryos with both HBA and HBB genetic defect

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
HBAPreimplantation genetic diagnosisalpha-Thalassemia
HBBPreimplantation genetic diagnosisbeta-Thalassemia
Primary Outcome Measures
NameTimeMethod
Gardner grading of blastocystsembryo cultured in-vitro for 5-7 days

development status of blastocysts

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Reproductive & Genetic Hospital of CITIC-XIANGYA

🇨🇳

Changsha, Hunan, China

© Copyright 2025. All Rights Reserved by MedPath